Lusutrombopag is primarily used in the treatment of thrombocytopenia, a condition characterized by abnormally low levels of platelets in the blood. It is specifically indicated for patients with chronic liver disease who are scheduled to undergo a medical or dental procedure. By stimulating the production of platelets, it helps reduce the risk of bleeding during these procedures. This medication is particularly beneficial for patients who cannot undergo platelet transfusions or who seek to avoid them. It is administered orally, making it a convenient option for outpatient management. The use of this drug has shown significant improvement in platelet counts, thereby enhancing the safety and feasibility of planned interventions in affected individuals.